• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基糖苷类药物在耐药性不断出现的时代的效用。

The utility of aminoglycosides in an era of emerging drug resistance.

作者信息

Zembower T R, Noskin G A, Postelnick M J, Nguyen C, Peterson L R

机构信息

Department of Medicine, Northwestern Memorial Hospital and Northwestern University Medical School, Chicago, IL 60611, USA.

出版信息

Int J Antimicrob Agents. 1998 May;10(2):95-105. doi: 10.1016/s0924-8579(98)00033-8.

DOI:10.1016/s0924-8579(98)00033-8
PMID:9716286
Abstract

As the problem of global antibiotic resistance continues to worsen, aminoglycosides have assumed increasing importance in clinical practice. Their broad antimicrobial spectrum, rapid bactericidal action, and ability to act synergistically with other drugs have made them especially useful in the treatment of serious nosocomial infections. However, as with other drugs, their overuse and misuse leads to the development of resistance in important microbial pathogens. The appropriate use of the aminoglycosides is essential to assure their continued efficacy. Therefore, physicians must familiarize themselves with both the clinical indications and the limitations of these drugs if they are to remain efficacious in the years to come.

摘要

随着全球抗生素耐药性问题持续恶化,氨基糖苷类药物在临床实践中的重要性日益凸显。它们广泛的抗菌谱、快速的杀菌作用以及与其他药物协同作用的能力,使其在治疗严重医院感染方面特别有用。然而,与其他药物一样,它们的过度使用和滥用会导致重要微生物病原体产生耐药性。合理使用氨基糖苷类药物对于确保其持续有效性至关重要。因此,如果要在未来几年保持疗效,医生必须熟悉这些药物的临床适应症和局限性。

相似文献

1
The utility of aminoglycosides in an era of emerging drug resistance.氨基糖苷类药物在耐药性不断出现的时代的效用。
Int J Antimicrob Agents. 1998 May;10(2):95-105. doi: 10.1016/s0924-8579(98)00033-8.
2
Aminoglycosides: current role in antimicrobial therapy.氨基糖苷类药物:在抗菌治疗中的当前作用。
Pharmacotherapy. 1988;8(6):334-50. doi: 10.1002/j.1875-9114.1988.tb04092.x.
3
In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.在医院获得性肺炎中,优化除氨基糖苷类以外的抗生素是临床成功结局更重要的决定因素,也是避免耐药性的更好方法。
Semin Respir Infect. 1997 Dec;12(4):278-93.
4
[Treatment of severe infections: should one always administer an aminoglycoside?].[严重感染的治疗:是否总是应该使用氨基糖苷类药物?]
Schweiz Med Wochenschr Suppl. 1996;76:28S-33S.
5
Aminoglycosides.
Med Clin North Am. 1995 Jul;79(4):761-87. doi: 10.1016/s0025-7125(16)30038-4.
6
New intervention strategies for reducing antibiotic resistance.
Chest. 1999 Mar;115(3 Suppl):24S-27S. doi: 10.1378/chest.115.suppl_1.24s.
7
[The use of antibiotic combinations].[抗生素联合使用]
Tidsskr Nor Laegeforen. 1973 Jun 30;93(18):1405-7.
8
Combination antibiotic therapy is appropriate for nosocomial pneumonia in the intensive care unit.联合抗生素治疗适用于重症监护病房的医院获得性肺炎。
Semin Respir Infect. 1993 Dec;8(4):268-84.
9
Future trends in aminoglycoside therapy.氨基糖苷类药物治疗的未来趋势。
Am J Med. 1986 Jun 30;80(6B):190-4. doi: 10.1016/0002-9343(86)90500-0.
10
Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.微生物监测和抗菌药物管理策略可最大程度减少创伤重症监护病房医院获得性感染治疗中超广谱联合治疗的需求:基于证据的经验性抗菌药物政策的审核。
S Afr Med J. 2013 Mar 15;103(6):371-6. doi: 10.7196/samj.6459.

引用本文的文献

1
Diadenosine tetraphosphate modulated quorum sensing in bacteria treated with kanamycin.双腺苷四磷酸调节庆大霉素处理细菌的群体感应。
BMC Microbiol. 2023 Nov 17;23(1):353. doi: 10.1186/s12866-023-03113-3.
2
Vancomycin Use in Children and Neonates across Three Decades: A Bibliometric Analysis of the Top-Cited Articles.三个十年间儿童及新生儿万古霉素的使用:高被引文章的文献计量分析
Pathogens. 2021 Oct 18;10(10):1343. doi: 10.3390/pathogens10101343.
3
Gentamicin-Loaded Chitosan Nanoparticles Improve Its Therapeutic Effects on -Infected J774A.1 Murine Cells.
载有庆大霉素的壳聚糖纳米颗粒提高其对感染的J774A.1小鼠细胞的治疗效果。
Galen Med J. 2019 Oct 29;8:e1296. doi: 10.31661/gmj.v8i0.1296. eCollection 2019.
4
Aminoglycosides Antagonize Bacteriophage Proliferation, Attenuating Phage Suppression of Bacterial Growth, Biofilm Formation, and Antibiotic Resistance.氨基糖苷类抗生素拮抗噬菌体增殖,减弱噬菌体对细菌生长、生物膜形成和抗生素耐药性的抑制作用。
Appl Environ Microbiol. 2021 Jul 13;87(15):e0046821. doi: 10.1128/AEM.00468-21.
5
An audiological profile of patients infected with multi-drug resistant tuberculosis at a district hospital in KwaZulu-Natal.夸祖鲁 - 纳塔尔省一家地区医院中耐多药结核病感染患者的听力学概况。
S Afr J Commun Disord. 2016 Nov 25;63(1):e1-e12. doi: 10.4102/sajcd.v63i1.154.
6
Frequency of Aminoglycoside-Resistance Genes in Methicillin-Resistant (MRSA) Isolates from Hospitalized Patients.来自住院患者的耐甲氧西林金黄色葡萄球菌(MRSA)分离株中氨基糖苷类耐药基因的频率
Jundishapur J Microbiol. 2016 Jul 26;9(8):e35052. doi: 10.5812/jjm.35052. eCollection 2016 Aug.
7
2-Deoxystreptamine Conjugates by Truncation-Derivatization of Neomycin.通过新霉素的截短衍生化制备的2-脱氧链霉胺缀合物
Pharmaceuticals (Basel). 2010 Mar 15;3(3):679-701. doi: 10.3390/ph3030679.
8
A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.将抗生素与噬菌体联合使用以控制细菌病原体铜绿假单胞菌的机遇之窗。
PLoS One. 2014 Sep 26;9(9):e106628. doi: 10.1371/journal.pone.0106628. eCollection 2014.
9
An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.脓毒症和感染性休克的另一种病理生理模式:优化抗菌治疗的意义。
Virulence. 2014 Jan 1;5(1):80-97. doi: 10.4161/viru.26913. Epub 2013 Nov 1.
10
Diversity in the antimicrobial susceptibility patterns of methicillin-resistant Staphylococcus aureus clones.耐甲氧西林金黄色葡萄球菌克隆的抗菌药物敏感性模式的多样性。
Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3317-21. doi: 10.1007/s10096-012-1698-3. Epub 2012 Jul 25.